Wednesday 2/21 Insider Buying Report: IOVA, RVP

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

At Iovance Biotherapeutics, a filing with the SEC revealed that on Tuesday, Director Merrill A. McPeak purchased 250,000 shares of IOVA, at a cost of $9.15 each, for a total investment of $2.29M. So far McPeak is in the green, up about 52.3% on their purchase based on today's trading high of $13.94. Iovance Biotherapeutics is trading up about 12.4% on the day Wednesday. Before this latest buy, McPeak made one other buy in the past twelve months, purchasing $55,600 shares for a cost of $5.56 each.

And at Retractable Technologies, there was insider buying on Friday, by PRESIDENT AND CEO Thomas J. Shaw who purchased 21,687 shares for a cost of $1.28 each, for a total investment of $27,768. Before this latest buy, Shaw purchased RVP on 30 other occasions during the past twelve months, for a total cost of $164,913 at an average of $1.15 per share. Retractable Technologies is trading up about 1.2% on the day Wednesday.

VIDEO: Wednesday 2/21 Insider Buying Report: IOVA, RVP

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.